We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.83B
AUM Growth
+$108M
(+2.3%)
Cap. Flow
+$83.9M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
12.94%
Holding
1,335
New
249
Increased
372
Reduced
442
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$35.5M |
| 2 |
CVS Health
CVS
|
+$32.5M |
| 3 |
Biogen
BIIB
|
+$24.9M |
| 4 |
Citigroup
C
|
+$23.8M |
| 5 |
PAY
Verifone Systems Inc
PAY
|
+$21.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Targa Resources
TRGP
|
+$31.7M |
| 2 |
Comcast
CMCSA
|
+$23.5M |
| 3 |
Verizon
VZ
|
+$23.2M |
| 4 |
Amazon
AMZN
|
+$22.2M |
| 5 |
Eli Lilly
LLY
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Financials | 15.76% |
| 3 | Healthcare | 13.7% |
| 4 | Industrials | 10.3% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEE
801
DELISTED
Sealed Air
SEE
| $417K | 0.01% |
9,080
-2,800
| -24% | -$134K |
|
802
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $416K | 0.01% |
8,520
-11,597
| -58% | -$568K |
|
803
Werner Enterprises
WERN
$2.54B
| $416K | 0.01% |
18,101
-57,512
| -76% | -$1.43M |
|
804
Standard BioTools
LAB
$326M
| $415K | 0.01% |
46,000
| – | – |
|
805
Affiliated Managers Group
AMG
$9.46B
| $411K | 0.01% |
+2,920
| New | +$478K |
|
|
ALR
806
DELISTED
AlerisLife Inc
ALR
| $411K | 0.01% |
17,581
-1,053
| -6% | -$22.7K |
|
|
TIER
807
DELISTED
TIER REIT, Inc.
TIER
| $411K | 0.01% |
+26,800
| New | +$399K |
|
|
ITG
808
DELISTED
Investment Technology Group Inc
ITG
| $410K | 0.01% |
24,538
+6,594
| +37% | +$124K |
|
|
LM
809
DELISTED
Legg Mason, Inc.
LM
| $408K | 0.01% |
+13,840
| New | +$449K |
|
810
Biglari Holdings Class B
BH
$1.2B
| $407K | 0.01% |
+1,514
| New | +$388K |
|
|
ATHX
811
DELISTED
Athersys, Inc. Common Stock
ATHX
| $407K | 0.01% |
+7,494
| New | +$425K |
|
812
Ameren
AEE
$31.5B
| $406K | 0.01% |
+7,570
| New | +$372K |
|
813
Rapid7
RPD
$634M
| $405K | 0.01% |
32,200
-18,100
| -36% | -$230K |
|
|
SCMP
814
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $404K | 0.01% |
36,800
-92,890
| -72% | -$1.04M |
|
815
QuinStreet
QNST
$870M
| $401K | 0.01% |
112,843
-8,200
| -7% | -$28K |
|
816
Robert Half
RHI
$3.61B
| $397K | 0.01% |
10,400
+80
| +0.8% | +$3.27K |
|
|
CTIC
817
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $397K | 0.01% |
+116,890
| New | +$536K |
|
818
Marchex
MCHX
$79.7M
| $392K | 0.01% |
123,263
-438
| -0.4% | -$1.65K |
|
819
Verastem
VSTM
$532M
| $392K | 0.01% |
25,105
-5,726
| -19% | -$101K |
|
|
GUID
820
DELISTED
Guidance Software, Inc.
GUID
| $392K | 0.01% |
63,313
-34,460
| -35% | -$183K |
|
|
EPZM
821
DELISTED
Epizyme, Inc
EPZM
| $391K | 0.01% |
+38,200
| New | +$426K |
|
822
Preferred Bank
PFBC
$1.22B
| $390K | 0.01% |
13,500
+3,470
| +35% | +$108K |
|
|
EXA
823
DELISTED
EXA Corporation
EXA
| $388K | 0.01% |
26,884
+6,801
| +34% | +$88K |
|
|
GNRT
824
DELISTED
Gener8 Maritime, Inc.
GNRT
| $387K | 0.01% |
60,400
+12,207
| +25% | +$86.6K |
|
825
Strategic Education
STRA
$1.71B
| $385K | 0.01% |
+7,830
| New | +$370K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2016 Portfolio in Review
As of Q2 2016, Jacobs Levy Equity Management held 1,335 positions worth $4.83B, up 2.3% from $4.72B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2016 filing shows 249 new, 372 increased, 442 reduced and 194 closed positions. Its largest new stake was CVS Health: 325,716 shares worth $31.2M. The largest sale was Targa Resources, an estimated $31.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q2 2016 buy was CVS Health: 325,716 shares worth $31.2M.
- Jacobs Levy Equity Management added most to Microsoft in Q2 2016, an estimated $35.5M increase.
- Jacobs Levy Equity Management's biggest Q2 2016 reduction was Comcast, cutting an estimated $23.5M.
- Jacobs Levy Equity Management fully exited Targa Resources in Q2 2016, selling an estimated $31.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.83B portfolio in Q2 2016.
- Jacobs Levy Equity Management opened 249 new positions and closed 194 in Q2 2016.
- Jacobs Levy Equity Management's portfolio value rose 2.3% quarter-over-quarter to $4.83B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2016, filed 15 Aug 2016.